Next Article in Journal
Review of the Clinical Experiences with the MitraClip Therapy
Previous Article in Journal
ESC Guidelines—Contributing to Quality in Clinical Practice
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cardiovascular Medicine
Volume 18
Issue 12
10.4414/cvm.2015.00367
cardiovascmed-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Perioperatives Management der Blutgerinnung: «alte» und «neue» Orale Antikoagulantien

by
Miodrag Filipovic
1,*,
Wolfgang Korte
2 and
Hans Rickli
3
1
Klinik für Anästhesiologie, Intensiv-, Rettungs- und Schmerzmedizin, Kantonsspital St. Gallen, St. Gallen, Switherland
2
Zentrum für Labormedizin, Hämostase- und Hämophiliezentrum St. Gallen, St. Gallen, Switherland
3
Klinik für Kardiologie, Departement Innere Medizin, Kantonsspital St. Gallen, St. Gallen, Switherland
*
Author to whom correspondence should be addressed.
Cardiovasc. Med. 2015, 18(12), 340; https://doi.org/10.4414/cvm.2015.00367
Submission received: 23 September 2015 / Revised: 23 October 2015 / Accepted: 23 November 2015 / Published: 23 December 2015
Versions Notes

Abstract

Perioperative management of blood coagulation: “old” and “new” anticoagulants. The perioperative management of patients receiving “old” and “new” oral anticoagulants is challenging and requires an interdisciplinary approach. Surgeons, anaesthetists, haematologists and cardiologists should elaborate guidelines that are mandatory for their institution. The risk and harmfulness of bleeding, the thromboembolic risk, the urgency of the procedure, and special circumstances (e.g., pregnancy, history of heparin- induced thrombocytopenia) have to be taken into consideration. Based on two case scenarios, the management of patients under treatment with direct oral anticoagulants and with vitamin K antagonists is discussed.
Keywords: management blood clotting; anticoagulation; direct oral anticoagulants; perioperative management management blood clotting; anticoagulation; direct oral anticoagulants; perioperative management

Share and Cite

MDPI and ACS Style

Filipovic, M.; Korte, W.; Rickli, H. Perioperatives Management der Blutgerinnung: «alte» und «neue» Orale Antikoagulantien. Cardiovasc. Med. 2015, 18, 340. https://doi.org/10.4414/cvm.2015.00367

AMA Style

Filipovic M, Korte W, Rickli H. Perioperatives Management der Blutgerinnung: «alte» und «neue» Orale Antikoagulantien. Cardiovascular Medicine. 2015; 18(12):340. https://doi.org/10.4414/cvm.2015.00367

Chicago/Turabian Style

Filipovic, Miodrag, Wolfgang Korte, and Hans Rickli. 2015. "Perioperatives Management der Blutgerinnung: «alte» und «neue» Orale Antikoagulantien" Cardiovascular Medicine 18, no. 12: 340. https://doi.org/10.4414/cvm.2015.00367

APA Style

Filipovic, M., Korte, W., & Rickli, H. (2015). Perioperatives Management der Blutgerinnung: «alte» und «neue» Orale Antikoagulantien. Cardiovascular Medicine, 18(12), 340. https://doi.org/10.4414/cvm.2015.00367

Article Metrics

Back to TopTop